Literature DB >> 20653250

Cognitive enhancement, cheating, and accomplishment.

Rob Goodman1.   

Abstract

An ethics of enhancement should not rest on blanket judgments; it should ask us to distinguish between the kinds of activities we want to enhance. Both students and academics have turned to cognition-enhancing drugs in significant numbers--but is their enhancement a form of cheating? The answer should hinge on whether the activity subject to enhancement is zero-sum or non-zero-sum, and whether one is more concerned with excellence in process or excellence in outcome. Cognitive enhancement should be especially tolerated when the activities at stake are non-zero-sum and when the importance of process is outweighed by the importance of outcome. The use of cognition-enhancing drugs does not unnaturally cheapen accomplishments achieved under their influence; instead, cognitive enhancement is in line with well-established conceptions of collaborative authorship, which shift the locus of praise and blame from individual creators to the ultimate products of their efforts.

Mesh:

Substances:

Year:  2010        PMID: 20653250     DOI: 10.1353/ken.0.0309

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  15 in total

1.  From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014.

Authors:  Ross D Aikins
Journal:  Hist Educ       Date:  2014-12-17

2.  "The White Version of Cheating?" Ethical and Social Equity Concerns of Cognitive Enhancing Drug Users in Higher Education.

Authors:  Ross Aikins
Journal:  J Acad Ethics       Date:  2018-12-11

3.  Judging cheaters: is substance misuse viewed similarly in the athletic and academic domains?

Authors:  Tonya Dodge; Kevin J Williams; Miesha Marzell; Rob Turrisi
Journal:  Psychol Addict Behav       Date:  2012-04-30

Review 4.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

Review 5.  Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Med Hypotheses       Date:  2013-09-17       Impact factor: 1.538

Review 6.  Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Authors:  Marisa E Marraccini; Lisa L Weyandt; Joseph S Rossi; Bergljot Gyda Gudmundsdottir
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 7.  Attitudes toward pharmacological cognitive enhancement-a review.

Authors:  Kimberly J Schelle; Nadira Faulmüller; Lucius Caviola; Miles Hewstone
Journal:  Front Syst Neurosci       Date:  2014-04-17

Review 8.  Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain.

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Front Syst Neurosci       Date:  2014-05-13

9.  "It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England.

Authors:  Elisabeth J Vargo; Andrea Petróczi
Journal:  Front Psychol       Date:  2016-05-27

10.  Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.

Authors:  Hannah Maslen; Nadira Faulmüller; Julian Savulescu
Journal:  Front Syst Neurosci       Date:  2014-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.